Study visit (days) | Treatment group | N | Asexual density by qRT-PCR, median (IQR) | Gametocyte density by qRT-PCR, median (IQR) |
---|---|---|---|---|
0 | ACT | 50 | 289.3 (29.4–1724.5) | 77.3 (37.1–124.0) |
ACT + PQ | 50 | 692.4 (55.1–4247.6) | 60.3 (24.8–175.9) | |
2 | ACT | 50 | 0 (0–1.2) | 62.6 (30.23–116.5) |
ACT + PQ | 49 | 0.2 (0–1.5) | 38.6 (10.3–114.2) | |
7 | ACT | 50 | 0 (0–0.1) | 41.6 (17.0–68.2) |
ACT + PQ | 48 | 0 (0–0.2) | 0.1 (0–0.8) | |
14 | ACT | 49 | 0 (0) | 19.2 (9.2–36.4) |
ACT + PQ | 48 | 0 (0–0.1) | 0 (0–0.1) | |
21 | ACT | 44 | 0 (0) | 4.9 (2.1–12.7) |
ACT + PQ | 46 | 0 (0) | 0 (0) | |
28 | ACT | 45 | 0 (0) | 0.8 (0.1–2.3) |
ACT + PQ | 45 | 0 (0) | 0 (0) | |
35 | ACT | 45 | 0 (0) | 0.1 (0–0.7) |
ACT + PQ | 45 | NA | NA | |
42 | ACT | 44 | 0 (0) | 0 (0–0.1) |
ACT + PQ | 45 | NA | NA | |
49 | ACT | 44 | 0 (0) | 0 (0) |
ACT + PQ | 45 | NA | NA |